SCIENTIFIC PRESENTATIONS & PUBLICATIONS

Scientific Presentations

EASD 2025

September 15-19, 2025

MET-233 is a differentiated efficacious amylin analogue in preclinical studies, combinable with MET-097, an ultra-long acting GLP-1 receptor agonist
View Presentation

EASD 2025

September 15-19, 2025

Therapeutic NuSH cocktails: co-administration of an ultra-long acting PYY analogue engineered for tolerability and an ultra-long acting GLP-1 analogue induces significant weight loss in DIO mice
View Poster

EASD 2025

September 15-19, 2025

Pharmacokinetics, weight loss, and tolerability of the ultra-long acting amylin analog MET-233
View Presentation

85TH SCIENTIFIC SESSIONS OF THE AMERICAN DIABETES ASSOCIATION®

June 22, 2025

A Twelve-Week Trial of MET-097—A Potent and Ultra-Long-Acting GLP-1 Receptor Agonist
View Poster

85TH SCIENTIFIC SESSIONS OF THE AMERICAN DIABETES ASSOCIATION®

June 22, 2025

Safety, Tolerability, PK, and Efficacy of MET-097—A Next-Generation Nutrient-Stimulated Hormone Peptide Analog for Chronic Weight Management
View Poster

85TH SCIENTIFIC SESSIONS OF THE AMERICAN DIABETES ASSOCIATION®

June 20-23, 2025

MET-097: Preclinical Characterization of a Potent and Ultra-Long-Acting GLP-1 Receptor Agonist
View Poster

85TH SCIENTIFIC SESSIONS OF THE AMERICAN DIABETES ASSOCIATION®

June 20-23, 2025

Cellular Characterisation of Signalling and Receptor Trafficking Induced by MET-097, a G Protein-Biased GLP-1R Agonist
View Poster

85TH SCIENTIFIC SESSIONS OF THE AMERICAN DIABETES ASSOCIATION®

June 20-23, 2025

MET-233 Is an Ultra-Long-Acting Amylin Receptor Agonist
View Poster

85TH SCIENTIFIC SESSIONS OF THE AMERICAN DIABETES ASSOCIATION®

June 20-23, 2025

Therapeutic NuSH Cocktails—Coadministration of Ultra-Long-Acting GLP-1, GIP, Glucagon, and Amylin Peptide Analogs Induce Profound Weight Loss in DIO Mice
View Poster

85TH SCIENTIFIC SESSIONS OF THE AMERICAN DIABETES ASSOCIATION®

June 20-23, 2025

Titration to Maintenance Doses of GLP-1R Agonists for Overweight and Obesity Is Suboptimal for Majority of Patients—Evidence from a Real-World Claims Dataset
View Poster

Scientific Publications

Coming Soon